Preparation and investigation of hydrolyzed polyacrylonitrile as a preliminary biomedical hydrogel
Source abstract
Abstract
Abstract Background Hydrolyzed polyacrylonitrile (HPAN) ha s attracted much attention as a hydrogel for a broad range of biomedical applications . Therefore, in this study, we prepared HPAN derivatives with controllable compositions by the radical polymerization of acrylonitrile (AN), methacrylic acid (MAA) and N -isopropylacrylamide (NIPAM) monomers. Results The prepared poly(AN-co-MAA-co-NIPAM) copolymers had different ratios of AN, MAA, and NIPAM and molecular weights ranging from 2000 to 50,000. The copolymers were prepared as films to examine their properties. The prepared copolymer films showed different solubilities, contact angles, and swelling ratios. The properties of the copolymer films were affected by the hydrophobic PAN segments and the hydrophilic PMAA or PNIPAM segments. Conclusion Thus, we conclude that introducing PMAA and PNIPAM segments with different ratios and lengths into PAN segments could represent a method of controlling the hydrogel properties of copolymers.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Hydrogels: synthesis, properties, applications · Advanced Cellulose Research Studies · Polymer Surface Interaction Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Molecular Science and Technology, Ajou University, Suwon 443-759, South Korea.
R&DB Center, Cellumed Co., Ltd., Seoul 153-803, South Korea.
Center for Biomaterials, Korea Institute of Science and Technology, Seoul 136-791, South Korea.
Funding
Small and Medium Business Administration
References (22)
Show source-provided references
1. 10.1186/2055-7124-18-610.1186/2055-7124-18-6 ↗
2. 10.1080/15583724.2014.98324410.1080/15583724.2014.983244 ↗
3. 10.1080/15583724.2014.98324410.1080/15583724.2014.983244 ↗
4. 10.1186/2055-7124-18-510.1186/2055-7124-18-5 ↗
5. 10.1080/15583724.2012.75192310.1080/15583724.2012.751923 ↗
6. 10.1039/C5TB01542A10.1039/C5TB01542A ↗
7. 10.1016/j.memsci.2007.05.01210.1016/j.memsci.2007.05.012 ↗
8. 10.1016/j.biomaterials.2013.01.00610.1016/j.biomaterials.2013.01.006 ↗
9. 10.1038/srep0706410.1038/srep07064 ↗
10. 10.1016/j.biomaterials.2014.03.04510.1016/j.biomaterials.2014.03.045 ↗
11. 10.1038/srep1471310.1038/srep14713 ↗
12. 10.1002/app.128210.1002/app.1282 ↗
13. 10.1089/ees.2014.016910.1089/ees.2014.0169 ↗
14. 10.1007/s12010-014-1186-610.1007/s12010-014-1186-6 ↗
15. 10.1002/pola.1990.08028062610.1002/pola.1990.080280626 ↗
16. 10.1002/(SICI)1522-9505(19981101)260:1<25::AID-APMC25>3.0.CO;2-K10.1002/(SICI)1522-9505(19981101)260:1<25::AID-APMC25>3.0.CO;2-K ↗
17. 10.1002/app.2391710.1002/app.23917 ↗
18. 10.1016/S0272-6386(89)80151-910.1016/S0272-6386(89)80151-9 ↗
19. 10.1093/ndt/18.2.25210.1093/ndt/18.2.252 ↗
20. Czop JK, Austen KF. Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte beta-glucan receptor. J Immunol. 1985;135:3388–3393.10.4049/jimmunol.135.5.3388 ↗
21. 10.1016/j.biomaterials.2010.02.02110.1016/j.biomaterials.2010.02.021 ↗
22. 10.1186/2055-7124-18-810.1186/2055-7124-18-8 ↗